368
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Health effects of occupational exposure to uranium: Do physicochemical properties matter?

, &
Pages 1104-1113 | Received 01 Nov 2013, Accepted 07 Jul 2014, Published online: 11 Jul 2014

References

  • Advisory Group on Ionising Radiation (AGIR). 2010. Circulatory disease risk. Report of the Independent Advisory Group on Ionising Radiation [accessed 25 January 2014]. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1284475204588.
  • Ansoborlo E, Chazel V, Hengé-Napoli MH, Pihet P, Rannou A, Bailey MR, Stradling N. 2002. Determination of the physical and chemical properties, biokinetics, and dose coefficients of uranium compounds handled during nuclear fuel fabrication in France. Health Phys 82:279–289.
  • Atkinson WD, Law DV, Bromley KJ, Inskip HM. 2004. Mortality of employess of the United Kingdom Atomic Energy Authority, 1946–97. Occupat Environ Med 61:577–585.
  • Agency for Toxic Substances & Disease Registry (ATSDR). 2012. Toxicological profile for uranium [accessed 1 February 2014]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp150.pdf.
  • Bahr DE, Aldrich TE, Seidu D, Brion GM, Tollerud DJ. 2011. Occupational exposure to trichloroethylene and cancer risk for workers at the Paducah Gaseous Diffusion Plant. Int J Occupat Med Environ Health 24:67–77.
  • Baysson H, Laurier D, Tirmarche M, Valenty M, Giraud JM. 2000. Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occupat Environ Med 57:188–194.
  • Beral V, Inskip H, Fraser P, Booth M, Coleman D, Rose G. 1985. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946–1979. BMJ 291:440–447.
  • Beral V, Fraser P, Carpenter L, Booth M, Brown A, Rose G. 1988. Mortality of employees of the Atomic Weapons Establishment, 1951–82. BMJ 297:757–770.
  • Bogers RP, van Leeuwen FE, Grievink L, Schouten LJ, Kiemeney LALM, Schram-Bijkerk D. 2013. Cancer incidence in Dutch Balkan veterans. Cancer Epidemiol 37:550–555.
  • Boice JD Jr, Cohen SS, Mumma MT, Chadda B, Blot WJ. 2007. Mortality among residents of Uravan, Colorado who lived near a uranium mill, 1936–84. J Radiolog Protect 27:299–319.
  • Boice JD Jr, Cohen SS, Mumma MT, Chadda B, Blot WJ. 2008. A cohort study of uranium millers and miners of Grants, New Mexico, 1979–2005. J Radiolog Protect 28:303–325.
  • Boice JD Jr, Marano DE, Cohen SS, Mumma MT, Blot WJ, Brill AB, Fryzek JP, Henderson BE, McLaughlin JK. 2006. Mortality among Rocketdyne workers who tested rocket engines, 1948–1999. J Occupat Environ Med 48:1070–1092.
  • Boice JD Jr, Cohen SS, Mumma MT, Ellis ED, Eckerman KF, Leggett RW, Boecker BB, Brill AB, Henderson BE. 2011. Updated mortality analysis of radiation workers at Rocketdyne (Atomics International), 1948–2008. Radiat Res 176:244–258.
  • Canu IG, Ellis ED, Tirmarche M. 2008. Cancer risk in nuclear workers occupationally exposed to uranium-emphasis on internal exposure. Health Phys 94:1–17.
  • Canu IG, Cardis E, Metz-Flamant C, Caër-Lorho S, Auriol B, Wild P, Laurier D, Tirmarche M. 2010. French cohort of the uranium processing workers: Mortality pattern after 30-year follow-up. Int Arch Occupat Environ Health 83:301–308.
  • Canu IG, Jacob S, Cardis E, Wild P, Caër S, Auriol B, Garsi JP, Tirmarche M, Laurier D. 2011. Uranium carcinogenicity in humans might depend on the physical and chemical nature of uranium and its isotopic composition: Results from pilot epidemiological study of French nuclear workers. Cancer Causes Control 22:1563–1573.
  • Carpenter L, Higgins C, Douglas A, Fraser P, Beral V, Smith P. 1994. Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946–1988. Radiat Res 138:224–238.
  • Carpenter LM, Higgins CD, Douglas AJ, Maconochie NES, Omar RZ, Fraser P, Beral V, Smith PG. 1998. Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. Br J Cancer 78:1224–1232.
  • Chan C, Hughes TS, Muldoon S, Aldrich T, Rice C, Hornung R, Brion G, Tollerud DJ. 2010. Mortality patterns among Paducah Gaseous Diffusion Plant Workers. J Occupat Environ Med 52:725–732.
  • Checkoway H, Pearce N, Kriebel D. 2004. Research methods in occupational epidemiology, 2nd ed. Oxford: Oxford University Press.
  • Checkoway H, Pearce N, Crawford-Brown DJ, Cragle DL. 1988. Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol 127:255–266.
  • Cragle DL, McLain RW, Qualters JR, Hickey JLS, Wilkinson GS, Tankersley WG, Lushbaugh CC. 1988. Mortality among workers at a nuclear fuels production facility. Am J Industrial Med 14:379–401.
  • Daniels RD, Bertke S, Waters KM, Schubauer-Berigan MK. 2013. Risk of leukaemia mortality from exposure to ionising radiation in US nuclear workers: A pooled case-control study. Occupat Environ Med 70:41–48.
  • Dupree-Ellis E, Watkins J, Ingle JN, Phillips J. 2000. External radiation exposure and mortality in a cohort of uranium processing workers. Am J Epidemiol 152:91–95.
  • Dupree EA, Cragle DL, McLain RW, Crawford-Brown DJ, Teta MJ. 1987. Mortality among workers at a uranium processing facility, the Linde Air Products Company Ceramics Plant, 1943–1949. Scand J Work, Environ Health 13:100–107.
  • Dupree EA, Watkins JP, Ingle JN, Wallace PW, West CM, Tankersley WG. 1995. Uranium dust exposure and lung cancer risk in four uranium processing operations. Epidemiology 6:370–375.
  • Fraser P, Carpenter L, Maconochie N, Higgins C, Booth M, Beral V. 1993. Cancer mortality and morbidity in employees of the United Kingdom atomic energy authority, 1946–86. Br J Cancer 67: 615–624.
  • Frome EL, Cragle DL, McLain RW. 1990. Poisson regression analysis of the mortality among a cohort of World War II nuclear industry workers. Radiat Res 123:138–152.
  • Frome EL, Cragle DL, Watkins JP, Wing S, Shy CM, Tankersley WG, West CM. 1997. A mortality study of employees of the nuclear industry in Oak Ridge, Tennessee. Radiat Res 148:64–80.
  • Gibb H, Fulcher K, Nagarajan S, McCord S, Fallahian NA, Hoffman HJ, Haver C, Tolmachev S. 2013. Analyses of radiation and mesothelioma in the US transuranium and uranium registries. Am J Public Health 103:710–716.
  • Guseva Canu I, Garsi JP, Caër-Lorho S, Jacob S, Collomb P, Acker A, Laurier D. 2012. Does uranium induce circulatory diseases? First results from a French cohort of uranium workers. Occupat Environ Med 69:404–409.
  • Guseva Canu I, Molina G, Goldberg M, Collomb P, David JC, Perez P, Paquet F, Tirmarche M. 2008. Development of a job exposure matrix for the epidemiological follow-up of workers in the French nuclear industry. Results of a pilot study. Revue d’Epidemiologie et de Sante Publique 56:21–29.
  • Guseva Canu I, Laurier D, Caër-Lorho S, Samson E, Timarche M, Auriol B, Bérard P, Collomb P, Quesne B, Blanchardon E. 2010. Characterisation of protracted low-level exposure to uranium in the workplace: A comparison of two approaches. Int J Hygiene Environ Health 213:270–277.
  • Gustavsson P, Talbäck M, Lundin A, Lagercrantz B, Gyllestad PE, Fornell L. 2004. Incidence of cancer among Swedish military and civil personnel involved in UN missions in the Balkans 1989–99. Occupat Environ Med 61:171–173.
  • Hooper TI, DeBakey SF, Nagaraj BE, Bellis KS, Smith B, Smith TC, Gackstetter GD. 2008. The long-term hospitalization experience following military service in the 1991 Gulf War among veterans remaining on active duty, 1994–2004. BMC Public Health 8:60.
  • International Commission on Radiological Protection (ICRP). 1994. Publication 66. Human respiratory tract model for radiological protection. Oxford: Pergamon Press.
  • Kang HK, Bullman TA. 1996. Mortality among U.S. veterans of the Persian Gulf War. New Eng J Med 335:1498–1504.
  • Kang HK, Bullman TA. 2001. Mortality among US veterans of the Persian Gulf War: 7-year follow-up. Am J Epidemiol 154:399–405.
  • Laurier D, Guseva Canu I, Baatout S, Bertho JM, Blanchardon E, Bouffler S, Cardis E, Gomolka M, Hall J, Kesminiene A, et al. 2012. DoReMi workshop on multidisciplinary approaches to evaluating cancer risks associated with low-dose internal contamination. Radioprotection 47:119–148.
  • Leggett RW, Eckerman KF, McGinn RA. 2012. Controlling intake of uranium in the workplace: Applications of biokinetic modeling and occupational monitoring data. [accessed 20 February 2014]. Available from: http://ordose.ornl.gov/documents/ORNL_TM-2012-14.pdf
  • Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis ESC, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, et al. 2012. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect 120:1503–1511.
  • Loomis DP, Wolf SH. 1996. Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947–1990. Am J Industrial Med 29:131–141.
  • Macfarlane GJ, Biggs AM, Maconochie N, Hotopf M, Doyle P, Lunt M. 2003. Incidence of cancer among UK Gulf war veterans: Cohort study. BMJ 327:1373–1375.
  • Macfarlane GJ, Hotopf M, Maconochie N, Blatchley N, Richards A, Lunt M. 2005. Long-term mortality amongst Gulf War Veterans: Is there a relationship with experiences during deployment and subsequent morbidity? Int J Epidemiol 34:1403–1408.
  • Marsh JW, Blanchardon E, Gregoratto D, Hofmann W, Karcher K, Nosske D, Tomášek L. 2012. Dosimetric calculations for uranium miners for epidemiological studies. Radiat Protect Dosimetry 149:371–383.
  • McDiarmid MA, Gaitens JM, Hines S, Breyer R, Wong-You-Cheong JJ, Engelhardt SM, Oliver M, Gucer P, Kane R, Cernich A and others. 2013. The Gulf War depleted uranium cohort at 20 years: Bioassay results and novel approaches to fragment surveillance. Health Phys 104:347–361.
  • McGeoghegan D, Binks K. 2000a. The mortality and cancer morbidity experience of workers at the Capenhurst uranium enrichment facility 1946–95. J Radiolog Protect 20:381–401.
  • McGeoghegan D, Binks K. 2000b. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946–95. J Radiolog Protect 20:111–137.
  • McGeoghegan D, Binks K, Gillies M, Jones S, Whaley S. 2008. The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946–2005. Int J Epidemiol 37:506–518.
  • Metz-Flamant C, Guseva Canu I, Laurier D. 2011. Malignant pleural mesothelioma risk among nuclear workers: A review. J Radiolog Protect 31:9–23.
  • Muirhead CR, O’Hagan JA, Haylock RGE, Phillipson MA, Willcock T, Berridge GLC, Zhang W. 2009. Mortality and cancer incidence following occupational radiation exposure: Third analysis of the National Registry for Radiation Workers. Br J Cancer 100: 206–212.
  • Peragallo MS, Lista F, Sarnicola G, Marmo F, Vecchione A. 2010. Cancer surveillance in Italian army peacekeeping troops deployed in Bosnia and Kosovo, 1996–2007: Preliminary results. Cancer Epidemiol 34:47–54.
  • Pinkerton LE, Bloom TF, Hein MJ, Ward EM. 2004. Mortality among a cohort of uranium mill workers: An update. Occupat Environ Med 61:57–64.
  • Polednak AP, Frome EL. 1981. Mortality among men employed between 1943 and 1947 at a uranium-processing plant. J Occupat Med 23:169–178.
  • Richardson DB, Wing S. 2006. Lung cancer mortality among workers at a nuclear materials fabrication plant. Am J Industrial Med 49: 102–111.
  • Richardson DB, Wing S, Keil A, Wolf S. 2013. Mortality among workers at Oak Ridge National Laboratory. Am J Industrial Med 56:725–732.
  • Ritz B. 1999. Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10:531–538.
  • Ritz B, Morgenstern H, Crawford-Brown D, Young B. 2000. The effects of internal radiation exposure on cancer mortality in nuclear workers at Rocketdyne/Atomics International. Environ Health Perspect 108:743–751.
  • Silver SR, Bertke SJ, Hein MJ, Daniels RD, Fleming DA, Anderson JL, Pinney SM, Hornung RW, Tseng CY. 2013. Mortality and ionising radiation exposures among workers employed at the Fernald Feed Materials Production Center (1951–1985). Occupat Environ Med 70:453–463.
  • Smith B, Smith TC, Ryan MAK, Gray GC. 2006. A comparison of the postdeployment hospitalization experience of U.S. military personnel following service in the 1991 gulf war, southwest asia after the gulf war, and Bosnia. J Occupat Environ Hygiene 3:660–670.
  • Snipes MB, McClellan RO, Mauderly JL, Wolff RK. 1989. Retention patterns for inhaled particles in the lung: Comparisons between laboratory animals and humans for chronic exposures. Health Phys 57:69–78.
  • Storm HH, Jørgensen HO, Kejs AMT, Engholm G. 2006. Depleted uranium and cancer in Danish Balkan veterans deployed 1992–2001. Eur J Cancer 42:2355–2358.
  • Tirmarche M, Harrison JD, Laurier D, Paquet F, Blanchardon E, Marsh JW. 2010. International Commission on Radiological Protection (ICRP), Publication 115. Lung cancer risk from radon and progeny and statement on radon. Annals ICRP 40:1–64.
  • United States Environmental Protection Agency (US EPA). 2012. Lymphohematopoietic cancers induced by chemicals and other agents: Overview and implications for risk assessment. [accessed 20 February 2014]. Available from: http://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_id = 507128
  • World Health Organization (WHO). 1998. International classification of diseases, 9th revision (ICD-9). Geneva: WHO.
  • World Health Organization (WHO). 2004. International classification of diseases, 10th revision (ICD-10). Geneva: WHO.
  • Yiin JH, Anderson JL, Daniels RD, Seel EA, Fleming DA, Waters KM, Chen PH. 2009. A nested case-control study of multiple myeloma risk and uranium exposure among workers at the Oak Ridge Gaseous Diffusion Plant. Radiat Res 171:637–645.
  • Young HA, Maillard JD, Levine PH, Simmens SJ, Mahan CM, Kang HK. 2010. Investigating the risk of cancer in 1990–1991 US Gulf War veterans with the use of State Cancer Registry data. Annals Epidemiol 20:265–272.
  • Zablotska LB, Lane RSD, Frost SE. 2013. Mortality (1950–1999) and cancer incidence (1969–1999) of workers in the Port Hope cohort study exposed to a unique combination of radium, uranium and γ-ray doses. BMJ Open 3(pii):e002159. doi: 10.1136/bmjopen-2012-002159. Print 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.